AIMEDBIO

PR
  • ENG
  • KOR
  • ABOUT US
    • Overview
    • Leadership
    • Corporate Governance
  • R&D
    • AimedBio’s Drug Development
    • P-ADC™
    • Pipeline
  • IR
    • Disclosure
    • Stock
    • Financial Information
  • PR
    • Notice
    • Press Release
    • Data Room
  • CAREERS
    • Our Culture
    • Recruitment Process
    • Job Opportunities

Press Release

36 posts
03
2026.02
[Press Release] AimedBio Signs Research Collaboration Agreement with AI Biomarker Company AIVIS, Acc.. VIEW MORE
26
2025.12
SK Plasma Triggers License Option for AimedBio's ROR1 ADC Candidate VIEW MORE
04
2025.12
AimedBio Debuts on KOSDAQ with USD 2 Billion Market Cap, Shares Surge 300% VIEW MORE
15
2025.10
AimedBio Entered into a Global Collaboration and Licensing Agreement with Boehringer Ingelheim VIEW MORE
22
2025.09
AimedBio Receives Approval for KOSDAQ Listing VIEW MORE
1 2 3 4 5

Location
9F, 10F, 11F MK Tower 67, Jeongui-ro, Songpa-gu, Seoul, Korea
CONTACT
(+82) 2-6285-0743
aimedbio@aimedbio.com
SOCIAL
aimedbio
ⓒ 2026 AimedBio Inc. All Rights Reserved.
Designed By Designpixel
  • Privacy Policy
  • Internal Information Management Regulation
  • Legal Disclaimer